The store will not work correctly when cookies are disabled.
(2R,3S)-3-propylmalic acid
ID: ALA226522
PubChem CID: 44423274
Max Phase: Preclinical
Molecular Formula: C7H12O5
Molecular Weight: 176.17
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Synonyms: (2R,3S)-3-Propylmalic Acid | (2R,3S)-3-propylmalic acid|CHEMBL226522
Canonical SMILES: CCC[C@H](C(=O)O)[C@@H](O)C(=O)O
Standard InChI: InChI=1S/C7H12O5/c1-2-3-4(6(9)10)5(8)7(11)12/h4-5,8H,2-3H2,1H3,(H,9,10)(H,11,12)/t4-,5+/m0/s1
Standard InChI Key: LOLHYFQEDPGSHZ-CRCLSJGQSA-N
Molfile:
RDKit 2D
12 11 0 0 1 0 0 0 0 0999 V2000
14.1164 -16.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8309 -15.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5487 -16.1868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8342 -14.9493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1169 -17.0165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4026 -17.4294 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8316 -17.4287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8344 -18.2556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5483 -17.0177 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4019 -15.7752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4017 -14.9502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6871 -14.5379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
5 7 1 6
2 4 2 0
7 8 1 0
7 9 2 0
1 5 1 0
1 10 1 6
1 2 1 0
10 11 1 0
5 6 1 0
11 12 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 176.17 | Molecular Weight (Monoisotopic): 176.0685 | AlogP: -0.07 | #Rotatable Bonds: 5 |
Polar Surface Area: 94.83 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.68 | CX Basic pKa: ┄ | CX LogP: 0.32 | CX LogD: -4.87 |
Aromatic Rings: ┄ | Heavy Atoms: 12 | QED Weighted: 0.54 | Np Likeness Score: 1.01 |
References
1. Yamamoto T, Miyazaki K, Eguchi T.. (2007) Substrate specificity analysis and inhibitor design of homoisocitrate dehydrogenase., 15 (3): [PMID:17116397] [10.1016/j.bmc.2006.11.008] |